It’s West Coast vs East Coast in CRISPR Fight

In a significant development for all of life science including orthopedics, the U.S. Court of Appeals for the Federal Circuit has reinstated the University of California, Berkeley’s legal challenge against the Broad Institute’s patents on CRISPR gene-editing technology. This decision revives a high-stakes dispute over the ownership of intellectual property rights for a technology with vast potential for all life science, pharmaceuticals and biotech generally.